Karyopharm Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KPTI and other ETFs, options, and stocks.About KPTI
Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A.
CEORichard A. Paulson
CEORichard A. Paulson
Employees279
Employees279
HeadquartersNewton, Massachusetts
HeadquartersNewton, Massachusetts
Founded2008
Founded2008
Employees279
Employees279
KPTI Key Statistics
Market cap128.01M
Market cap128.01M
Price-Earnings ratio-0.48
Price-Earnings ratio-0.48
Dividend yield—
Dividend yield—
Average volume235.47K
Average volume235.47K
High today$7.48
High today$7.48
Low today$6.85
Low today$6.85
Open price$7.07
Open price$7.07
Volume222.01K
Volume222.01K
52 Week high$12.45
52 Week high$12.45
52 Week low$3.51
52 Week low$3.51
Stock Snapshot
With a market cap of 128.01M, Karyopharm Therapeutics(KPTI) trades at $6.95. The stock has a price-to-earnings ratio of -0.48.
As of 2025-12-13, Karyopharm Therapeutics(KPTI) stock has fluctuated between $6.85 and $7.48. The current price stands at $6.95, placing the stock +1.5% above today's low and -7.1% off the high.
Karyopharm Therapeutics(KPTI) shares are trading with a volume of 222.01K, against a daily average of 235.47K.
During the past year, Karyopharm Therapeutics(KPTI) stock moved between $3.51 at its lowest and $12.45 at its peak.
During the past year, Karyopharm Therapeutics(KPTI) stock moved between $3.51 at its lowest and $12.45 at its peak.
Analyst ratings
83%
of 6 ratingsBuy
83.3%
Hold
16.7%
Sell
0%
People also own
Based on the portfolios of people who own KPTI. This list is generated using Robinhood data, and it’s not a recommendation.